BDBM62541 1-(2,3-Dimethyl-phenyl)-4-{phenyl-[1-(tetrahydro-furan-2-ylmethyl)-1H-tetrazol-5-yl]-methyl}-piperazine::1-(2,3-dimethylphenyl)-4-[[1-(2-oxolanylmethyl)-5-tetrazolyl]-phenylmethyl]piperazine::1-(2,3-dimethylphenyl)-4-[[1-(oxolan-2-ylmethyl)-1,2,3,4-tetrazol-5-yl]-phenyl-methyl]piperazine::1-(2,3-dimethylphenyl)-4-[[1-(oxolan-2-ylmethyl)tetrazol-5-yl]-phenylmethyl]piperazine::1-(2,3-dimethylphenyl)-4-[phenyl-[1-(tetrahydrofurfuryl)tetrazol-5-yl]methyl]piperazine::MLS000070806::SMR000004943::cid_647989

SMILES CCOCCn1nc2cc(N3CCOc4cc(C(=O)N5CCC(F)(F)CC5)cnc43)ccn2c1=O

InChI Key InChIKey=YSWDVDXLKARVHE-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62541   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62541BDBM62541(US12577217, Example 1-48)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent